- 1、本文档共14页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
CloseoutofNIHGrants.ppt-Officeof.ppt
Closeout of NIH Grants NCURA Region VI/VII Regional Meeting – Portland, OR Joe Ellis, Director Office of Policy for Extramural Research Administration What is “Closeout” Closeout is an “After-the-Award” activity officially ending the grant relationship. Defined in 45 CFR Part 74.71 Closeout Basics Recipients must submit all required financial, performance, and other reports as required by the grant. Recipients must liquidate all obligations incurred under the award. Agencies must make prompt payments for allowable, reimbursable grant costs Note: Closeout does not affect the right of an awarding agency to disallow costs and recover funds on the basis of later audits or other reviews. NIH Closeout Requirements Grantees must submit to NIH within 90 calendar days after the last day of the final budget period. Final Progress Report Final Financial Status Report Final Invention Statement Submit to eRA Commons (preferred) or NIH Centralized Processing Center Requirements detailed in the NIH Grants Policy Statement /grants/policy/nihgps_2003/NIHGPS_Part8.htm#_ToFinal Progress Report No required form or standard format Basic guidelines now provided in the PHS 2590 Progress Report Instructions. Include: Statement of progress toward the original grant aims. List of significant results (positive or negative). List of publications. If a competitive renewal (Type 2) has been submitted, whether funded or not, the progress report contained in that application may serve in lieu of a final progress report. Final Progress Report (cont.) Also include: Report on the inclusion of gender and minority study subjects. Where appropriate, indicate whether children were involved in the study or how the study was relevant for conditions affecting children. Describe any data, research materials (such as cell lines, DNA probes, animal models), protocols, software, or other research information that is available to be shared and how it may be accessed. Address any other specific
文档评论(0)